Skip to main content

Durham company sees promise in clinical trials for leukemia treatment

A Durham company's interim clinical trial results for a leukemia treatment have company executives optimistic about the treatment's future.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.